Ledger.Open graph →
SEC Form D · filed March 12, 2020

Amunix Pharmaceuticals, Inc

Offering
$83.6M
Sold
$83.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MOUNTAIN VIEW, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

James Brush · Mountain View, CADirectorJames Topper · Mountain View, CADirectorRichard Heyman · Mountain View, CADirectorOtello Stampacchia · Mountain View, CADirectorVolker Schellenberger · Mountain View, CAExecAngie You · Mountain View, CAExec · DirectorDavid Hirsch · Mountain View, CADirectorTodd J. Bazemore · Lexington, MADirectorBrandon Nielson · Salt Lake City, UTDirectorJohn Earl · Salt Lake City, UTExec · DirectorDaniel Sundheim · New York, NYDirectorSerena Kim · Bethesda, MDDirectorMonika Garg · Rancho Santa Fe, CADirectorAndrea Barthwell · Bethesda, MDExecGuido Mallmann · Buenos Aires, C1DirectorBrent C. Adam · PORTLAND, ORExec · DirectorAnthony J. Bash · PORTLAND, ORDirectorCharles E. Harrell · PORTLAND, ORDirectorStuart Peterson · Austin, TXDirectorFrank Levinson · SAN MATEO, CADirectorJulia Davourie · SAN MATEO, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗